article thumbnail

Simplifying Medication Management Allows Nurses to Focus More on Patient

Omnicell

Standardizing an interoperability solution that supports information exchange creates better medication management practices for nurses and improved patient engagement. Before the integration, medication dispensing typically occurred without a conversation at the patient's bedside.

article thumbnail

Revolutionizing Nursing: Eliminating Strain and Burnout Through Technological Efficiency

indispensable health

Technology offers a lifeline by automating documentation, report generation, and data entry: A. Electronic Health Records (EHRs): Embracing EHRs allows nurses to access patient information swiftly, reducing the need for manual chart searches and paperwork.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Future of Pharmacy Podcast: Achieving the Delicate Balance with OR Medication Management

Omnicell

In a manual environment, you'll also see redundant documentation when an anesthesia professional is required to document all the administered medications on paper, then again in the electronic health record. Matching these two parties' needs with closed-loop technology is crucial for this type of environment to succeed.

article thumbnail

9 ways pharmacy technician roles are changing

The Checkup by Singlecare

A number of factors have fueled the transformation of the pharmacy tech role, says Dr. Staiger, including a growing demand for healthcare services, the need to improve operational efficiencies, and the increasing complexity of medications, dispensing requirements, and billings. Responsibilities vary, but may include: 1.

article thumbnail

New Breakthrough Devices Program Guidance: Expanding Opportunities for Medical Product Innovations

The FDA Law Blog

Background The Breakthrough Devices Program, established under section 515B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is a voluntary program for certain medical devices and device-led combination products. By Philip Won & Lisa M. Wysa, see here ) and addiction (e.g., reSET-O, see here , here ).

article thumbnail

(Slightly More) Options for cGMP for Combination Products: FDA Describes Alternative or Streamlined Mechanisms for Compliance

The FDA Law Blog

much like an FDA guidance document. Part 820, the list provides information on integration of the design control requirements within a pharmaceutical development program and discussion of exemption from cGMP requirements for applicable device constituents. The recent FR Notice does not modify § 4.4, Section 21 C.F.R 880.6430 ).

FDA 40